Biotech VC firm outlines plans for $100M fund
An early-stage biotech investor called YK Bioventures plans to raise $100 million, according to an SEC filing on Wednesday.
The VC …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
